Insights
Market commentary and guides
Buy Healthscope
We recommend buying Healthscope following the share price retracing from the recent high and filling the technical price gap down to $2.10.
CYB – Long-term Value
We continue to see long-term value in CYB following the recent share price correction. Should CYB deliver on its original cost synergy targets, (following…
Aristocrat Leisure Reports FY18 Earnings
Aristocrat Leisure reported a 30% increase in FY18 after tax earnings at A$730m. The result was slightly below consensus and recent digital acquisitions were…
Buy Downer EDI – Technical Support
We recommend buying Downer EDI as the price action begins to find support at the 2018 low of $6.20. The company recently reiterated their…
James Hardie – Oversold
James Hardie is a current holding in the ASX 100 model portfolio and is under Algo Engine buy conditions. In the last Opportunities in…
Gold sell off weighs on Newcrest
As the US dollar rebounded last night, gold sold off -0.6% to $US 1214. NCM has been under Algo Engine sell signals since forming…
Crown, Tabcorp & Star Entertainment
We highlight the buying interest that is starting to build in Crown, Tabcorp and Star Entertainment. Crown and Tabcorp are current holdings within our…
Amcor – recovery continues
In our “Opportunities in Review” webinar series, Amcor was identified as a high conviction buy with an upside target of $14.50. The stock has…
Buy Healthscope
Our Algo Engine triggered a buy signal in Healthscope and it remains a current holding in the ASX 100 model portfolio. The retracement in…
S&P500 & Global 100
Our Algo Engine has generated buy signals in the IVV (S&P500) and IOO (Global 100) ETF. We see support building near the current lows.